DYSF and neuromuscular disease caused by qualitative or quantitative defects of dysferlin: Conversely, inhibition of proteasome activation results in a trend toward increased dysferlin and alleviates muscle inflammation (20), suggesting an important role of UPP in dysferlinopathy.